Clinical Trial Update: The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study of a single-dose GR2002 Injection in Chinese healthy volunteers has been completed, with asthma listed as the study condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GR2002 Injection

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Asthma | Phase 1 | Status: COMPLETED